SUBSCRIBE
SUBSCRIBE

Remedy Plan Therapeutics

IN THE PRESS
Press Releases
Remedy Plan Therapeutics Raises $18 Million Financing to Accelerate Advancement of Lead Asset RPT1G into Phase 1/2 Trials
May 14, 2025
 · 
3 min read
Press Releases
Remedy Plan Therapeutics Initiates Dosing in Phase 1 Clinical Trial of RPT1G, a First-In-Class Hyperbolic NAMPT Inhibitor
December 18, 2024
 · 
2 min read
Press Releases
UPDATE - Remedy Plan Therapeutics Showcases Preclinical Data from First-In-Class NAMPT Inhibitor, RPT1G, Demonstrating Synergy with BCL-2 Family Inhibitors in AML at the 2024 ASH Annual Meeting
December 11, 2024
 · 
3 min read
BioCapital
Remedy Plan Therapeutics Expands Leadership Team and Board of Directors
December 6, 2023
 · 
3 min read
JOBS